Development of an Effective Polyvalent Vaccine against both Marek's and Newcastle Diseases Based on Recombinant Marek's Disease Virus Type 1 in Commercial Chickens with Maternal Antibodies

An earlier report (M. Sakaguchi et al., Vaccine 16:472–479, 1998) showed that recombinant Marek's disease virus type 1 (rMDV1) expressing the fusion (F) protein of Newcastle disease virus (NDV-F) under the control of the simian virus 40 late promoter [rMDV1-US10L(F)] protected specific pathogen...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Sonoda, Kengo, Sakaguchi, Masashi, Okamura, Hiroshi, Yokogawa, Kenji, Tokunaga, Eiji, Tokiyoshi, Sachio, Kawaguchi, Yasushi, Hirai, Kanji
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2000
Gaiak:
Vaccines and Antiviral Agents
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC111822/
https://ncbi.nlm.nih.gov/pubmed/10708438
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak